APA (7th ed.) Citation

Bourillon, L., Bourgier, C., Gaborit, N., Garambois, V., Llès, E., Zampieri, A., . . . Chardès, T. (2019). An auristatin‐based antibody‐drug conjugate targeting HER3 enhances the radiation response in pancreatic cancer. International journal of cancer, 145(7), 1838-1851. https://doi.org/10.1002/ijc.32273

Chicago Style (17th ed.) Citation

Bourillon, Laura, et al. "An Auristatin‐based Antibody‐drug Conjugate Targeting HER3 Enhances the Radiation Response in Pancreatic Cancer." International Journal of Cancer 145, no. 7 (2019): 1838-1851. https://doi.org/10.1002/ijc.32273.

MLA (9th ed.) Citation

Bourillon, Laura, et al. "An Auristatin‐based Antibody‐drug Conjugate Targeting HER3 Enhances the Radiation Response in Pancreatic Cancer." International Journal of Cancer, vol. 145, no. 7, 2019, pp. 1838-1851, https://doi.org/10.1002/ijc.32273.